|Product Name||Human ADAM15 ELISA Kit|
|Customs Name||Human ADAM15 ELISA Kit|
|Assay Type||Sandwich ELISA|
|Suitable Sample Type||serum, plasma, cell culture supernates|
|Format||96-well strip plate|
|Storage||4℃ (unopened) standard stored at -20℃, others stored at 4℃ (opened)|
|Sample Volume||20 μl|
|Standard Curve Range||78.13 - 5000 pg/ml|
|Spike Recovery Range||82% - 116%|
|Mean Spike Recovery||1|
|CV of Intra plate||2.3% - 2.8 %|
|CV of Inter plate||1.5% - 2.9%|
|Components||96-well polystyrene microplate coated with a monoclonal antibody against ADAM15
Human ADAM15 Standard, lyophilized
ADAM15 Detect Antibody
Assay Buffer (10×)
Washing Buffer (20×)
|Describtion||This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human ADAM15. The Human ADAM15 ELISA is for research use only. Not for diagnostic or therapeutic procedures.
A disintegrin and metalloprotease domain-containing protein 15 (ADAM15), is a member of the ADAM (a disintegrin and metalloproteinase) protein family. ADAM family members are type I transmembrane glycoproteins known to be involved in cell adhesion and proteolytic ectodomain processing of cytokines and adhesion molecules. This protein contains multiple functional domains including a zinc-binding metalloprotease domain, a disintegrin-like domain, as well as an EGF-like domain. Through its disintegrin-like domain, this protein specifically interacts with the integrin beta chain, beta 3. It also interacts with Src family protein-tyrosine kinases in a phosphorylation-dependent manner, suggesting that this protein may function in cell-cell adhesion as well as in cellular signaling.
ADAM15 has been associated with a number of diseases, most recently Rheumatoid Arthritis. ADAM15 also has an antiapoptotic effect in osteoarthritic chondrocytes. It has also been shown to have a role in Prostate Cancer through increased expression in neoplastic and metastatic tissues compared to normal prostate tissues and also through its modulation of epithelial cell- tumour cell interactions. ADAM15 may represent a pivotal regulatory component of tumor progression or an important target for therapeutic intervention.